World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
10089
World Ranking
4411
National Ranking
2002

Overview

Lisa A. Cavacini is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research spans several fields, primarily focusing on Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Subfields of study include Infectious Diseases, Immunology, Parasitology, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

The scientist has contributed to research topics such as Vector-borne infectious diseases, Viral Infections and Vectors, Monoclonal and Polyclonal Antibodies Research, Toxin Mechanisms and Immunotoxins, SARS-CoV-2 and COVID-19 Research, Viral gastroenteritis research and epidemiology, and Escherichia coli research studies.

Frequent co-authors in their work include:

  • Yang Wang
  • Nicholas J. Mantis
  • Mark S. Klempner
  • Monir Ejemel
  • M. Rudolph

Publication venues where they have appeared most often are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Infection and Immunity
  • PLoS ONE
  • Open Forum Infectious Diseases

Key recent papers authored or co-authored by Lisa A. Cavacini include:

  • A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction, 2020, Nature Communications
  • Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design, 2021, Scientific Reports
  • Enteric Polymer-Coated Porous Silicon Nanoparticles for Site-Specific Oral Delivery of IgA Antibody, 2020, ACS Biomaterials Science & Engineering
  • IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model, 2020, Vaccine

Best Publications

  • Structure and function of immunoglobulins.

    Harry W. Schroeder;Lisa Cavacini

  • Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.

    Timothy W. Baba;Vladimir Liska;Regina Hofmann-Lehmann;Josef Vlasak

  • Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.

    A. Razzaque Ahmed;Zachary Spigelman;Lisa A. Cavacini;Marshall R. Posner

  • Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.

    Lei Chen;Young Do Kwon;Tongqing Zhou;Xueling Wu

  • Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody

    Dennis R. Burton;Ann J. Hessell;Brandon F. Keele;Per Johan Klasse

  • Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak

    Zachary A. Bornholdt;Hannah L. Turner;Charles D. Murin;Wen Li

  • Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120.

    Posner Mr;Cavacini La;Emes Cl;Power J

  • Postnatal Passive Immunization of Neonatal Macaques with a Triple Combination of Human Monoclonal Antibodies against Oral Simian-Human Immunodeficiency Virus Challenge

    Regina Hofmann-Lehmann;Josef Vlasak;Robert A. Rasmussen;Beverly A. Smith

  • Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine.

    Casie Kelly-Quintos;Casie Kelly-Quintos;Lisa A. Cavacini;Lisa A. Cavacini;Marshall R. Posner;Marshall R. Posner;Donald Goldmann;Donald Goldmann

  • A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.

    Monir Ejemel;Qi Li;Shurong Hou;Zachary A. Schiller

  • Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques.

    Flavia Ferrantelli;Regina Hofmann-Lehmann;Robert A. Rasmussen;Tao Wang

  • The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors.

    Susan E. Malenbaum;David Yang;Lisa Cavacini;Marshall Posner

  • Human Monoclonal Antibodies to Pseudomonas aeruginosa Alginate That Protect against Infection by Both Mucoid and Nonmucoid Strains

    Gerald B. Pier;Debra Boyer;Michael Preston;Fadie T. Coleman

  • Synergistic Neutralization of Simian-Human Immunodeficiency Virus SHIV-vpu+ by Triple and Quadruple Combinations of Human Monoclonal Antibodies and High-Titer Anti-Human Immunodeficiency Virus Type 1 Immunoglobulins

    An Li;Hermann Katinger;Marshall R. Posner;Marshall R. Posner;Lisa Cavacini;Lisa Cavacini

  • An agonist murine monoclonal antibody to the human c-Mpl receptor stimulates megakaryocytopoiesis.

    Bijia Deng;Naheed Banu;Beth Malloy;Philip Hass

  • Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41.

    Lisa A. Cavacini;Charlotte L. Emes;Adam V. Wisnewski;Jennifer Power

  • Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization

    Christian H. Bell;Ralph Pantophlet;André Schiefner;Lisa A. Cavacini

  • Structure of the Fab Fragment of F105, a Broadly Reactive Anti-Human Immunodeficiency Virus (HIV) Antibody That Recognizes the CD4 Binding Site of HIV Type 1 gp120

    Royce A. Wilkinson;Chayne Piscitelli;Martin Teintze;Lisa A. Cavacini

  • V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.

    D C Montefiori;B S Graham;J Zhou;R A Bucco

  • Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis

    Ralph Pantophlet;Rowena O. Aguilar-Sino;Terri Wrin;Lisa A. Cavacini;Lisa A. Cavacini

  • T-cell immunity in murine malaria: adoptive transfer of resistance to Plasmodium chabaudi adami in nude mice with splenic T cells.

    L A Cavacini;C A Long;W P Weidanz

Frequent Co-Authors

Marshall R. Posner
Marshall R. Posner Icahn School of Medicine at Mount Sinai
Mark S. Klempner
Mark S. Klempner University of Massachusetts Chan Medical School
Hermann Katinger
Hermann Katinger BOKU University
Ruth M. Ruprecht
Ruth M. Ruprecht Texas Biomedical Research Institute
David C. Montefiori
David C. Montefiori Duke University
Gerald B. Pier
Gerald B. Pier Brigham and Women's Hospital
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Regina Hofmann-Lehmann
Regina Hofmann-Lehmann University of Zurich
Kenneth H. Mayer
Kenneth H. Mayer Harvard Medical School
Joseph Sodroski
Joseph Sodroski Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various advanced healthcare careers, including Nurse Practitioner roles that complement immunological expertise. For those interested in nursing, exploring the easiest fnp program options can be a great starting point to balance rigorous academics with manageable course loads.

Mental health is another vital area linked to immunological research, where Psychiatric-Mental Health Nurse Practitioners (PMHNPs) play key roles. Choosing from the top pmhnp programs ensures quality clinical experiences, which are essential for hands-on learning and future job success.

Cost is often a major factor when selecting an online degree, and there are well-regarded cheapest pmhnp programs online available that offer solid education without breaking the bank. Affordability combined with strong outcomes should be a priority for aspiring healthcare professionals.

Finally, understanding compensation is crucial for long-term career planning. Doctor of Nursing Practice (DNP) holders specializing in immunology-related fields can reference data on how much do dnps make to gauge earning potential across different states.

Best Scientists Citing Lisa A. Cavacini

Trending Scientists

Recently Published Articles